Methods of treating alpha adrenergic mediated conditions

Details for Australian Patent Application No. 2009257692 (hide)

Owner Allergan, Inc.

Inventors Gomez, Dario G.; Garst, Michael E.; Nguyen, Phong X.; Sinha, Santosh C.; Fang, Wenkui K.; Heidelbaugh, Todd M.; Chow, Ken

Agent Davies Collison Cave

Pub. Number AU-A-2009257692

PCT Pub. Number WO2009/152052

Priority 61/059,837 09.06.08 US

Filing date 5 June 2009

Wipo publication date 17 December 2009

International Classifications

A61K 31/4168 (2006.01)

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

13 January 2011 PCT application entered the National Phase

  PCT publication WO2009/152052 Priority application(s): WO2009/152052

12 January 2012 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Gomez, Dario G.; Garst, Michael E.; Nguyen, Phong X.; Sinha, Santosh C.; Fang, Wenkui K.; Heidelbaugh, Todd M.; Chow, Ken; Gil, Daniel W.; Donello, John E.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009257705-Pre-fabricated storm shelter

2009257683-Controlling a phacoemulsification system based on real-time analysis of image data